Recent Developments In Life Sciences Enforcement and Regulatory Activity

Please join Skadden attorneys Nicole Grimm and John Barkmeyer for a review of recent life sciences enforcement and regulatory activities, along with a look ahead to upcoming developments. Our panelists will examine key settlements and other notable cases, discuss enforcement trends by key government agencies, review important statutory and regulatory changes, and make predictions about which developments might be on the horizon in the upcoming year.

This program is geared toward legal, compliance, and regulatory employees of life science companies, who are familiar with this area of law and will benefit from a focused discussion of recent developments and potential areas of enforcement risk.

Learning Objectives:

1. Discuss Food and Drug Administration regulatory and enforcement updates, including an exploration of new FDA requirements
2. Examine recent Department of Justice life sciences enforcement actions, including forward-looking compliance programs and key enforcement trends
3. Analyze recent False Claims Act life sciences investigations and settlements
4. Explore digital heath developments, including increased enforcement activity by the Federal Trade Commission